Eli Lilly (LLY) Q4 2024 Earnings Call Transcript

2 days ago · Eli Lilly (LLY 3.35%) Q4 2024 Earnings Call Feb 06, 2025, 10:00 a.m. ET. Contents: Prepared Remarks; Questions and Answers; Call Participants; Prepared Remarks: Operator. …

CouponFollow Extension

35%
OFF

Eli Lilly (LLY) Q4 2024 Earnings Call Transcript

2 weeks from now

2 days ago · Eli Lilly (LLY 3.35%) Q4 2024 Earnings Call Feb 06, 2025, 10:00 a.m. ET. Contents: Prepared Remarks; Questions and Answers; Call Participants; Prepared Remarks: Operator. …

fool.com

26%
OFF

Eli Lilly (LLY) Q4 2024 Earnings Call Transcript - Barchart.com

2 weeks from now

LLY earnings call for the period ending December 31, 2024. LLY earnings call for the period ending December 31, 2024. ... LLY: 872.67 +2.30 +0.26%: Eli Lilly and Company: Most …

barchart.com

$13.53
OFF

Transcript : Eli Lilly And Company, Q4 2024 Earnings Call, Feb 06, …

2 weeks from now

1 day ago · Earnings Flash (LLY) Eli Lilly and Co. Reports Q4 Revenue $13.53B, vs. FactSet Est of $13.53B 06:50am: MT Earnings Flash (LLY) Eli Lilly and Co. Posts Q4 Adjusted EPS $5.32, …

marketscreener.com

32%
OFF

Eli Lilly And Co (LLY) Q4 2024 Earnings Call Highlights: Record …

2 weeks from now

17 hours ago · Eli Lilly and Co reported a 32% increase in full-year revenue for 2024, exceeding guidance by $4 billion. The company achieved a 45% revenue growth in Q4 2024, driven by …

yahoo.com

7%
OFF

LLY | Eli Lilly And Earnings Transcripts - StockLight

2 weeks from now

Aug 8, 2023 · Eli Lilly and Earnings Transcripts NYSE:LLY (669.9B) Date Transcript Closing Price October 30th, 2024 Q3 2024 Earnings Call Transcript: $846.83 (-6.7%) August 8th, 2024 Q2 …

stocklight.com

45%
OFF

Eli Lilly Q4 Earnings: Now The Magical $1 Trillion Dollar Market …

2 weeks from now

Investment Overview. Eli Lilly and Company (NYSE:LLY) shared its Q4 and full-year earnings earlier today. Total revenues in Q4 grew by a very impressive 45% year-on-year, to $13.53bn, …

seekingalpha.com

$845
OFF

Eli Lilly (LLY) Q4 2024 Earnings Call Transcript - MSN

2 weeks from now

Eli Lilly (NYSE: LLY). Q4 2024 Earnings Call. Feb 06, 2025, 10:00 a.m. ET. Read More: Earn up to $845 cash back this year just by changing how you pay at Costco! Learn more here.

msn.com

48%
OFF

Eli Lilly (LLY) Q3 2024 Earnings Call Transcript

2 weeks from now

Oct 30, 2024 · Eli Lilly (LLY-1.48%) Q3 2024 Earnings Call Oct 30, 2024, 10:00 a.m. ET. Contents: Prepared Remarks; Questions and Answers; Call Participants; Prepared Remarks: …

fool.com

45%
OFF

Eli Lilly (LLY) Q4 2023 Earnings Call Transcript | The Motley Fool

2 weeks from now

Feb 6, 2024 · Eli Lilly (LLY 2.45%) Q4 2023 Earnings Call Feb 06, 2024, 10:00 a.m. ET. Contents: Prepared Remarks; Questions and Answers; Call Participants; Prepared Remarks: Operator. …

fool.com

45%
OFF

Eli Lilly (LLY) Q2 2024 Earnings Call Transcript

2 weeks from now

Aug 8, 2024 · Eli Lilly (LLY 2.45%) Q2 2024 Earnings Call Aug 08, 2024, ... As noted in our Q4 -- Q1 2024 earnings call, unprecedented demand for our incretin medicines led to wholesaler …

fool.com

FAQs about Eli Lilly (LLY) Q4 2024 Earnings Call Transcript Coupon?

How much does Eli Lilly (LLY) earn per share?

Eli Lilly (LLY) came out with quarterly earnings of $5.32 per share, beating the Zacks Consensus Estimate of $5.03 per share. This compares to earnings of $2.49 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 5.77%. ...

When will Eli Lilly report Q4 2024 earnings?

Eli Lilly is set to report Q4 2024 earnings on February 6, 2025, with management expecting $13.5 billion in revenue—a massive 45% year-over-year jump. Driving this surge? Explosive demand for its weight-loss drugs Mounjaro ($3.5 billion) and Zepbound ($1.9 billion). ...

Is Eli Lilly a good stock to buy in 2025?

Explosive demand for its weight-loss drugs Mounjaro ($3.5 billion) and Zepbound ($1.9 billion). Looking ahead, Lilly forecasts $58–$61 billion in 2025 revenue, marking a staggering 32% growth at the midpoint. Eli Lilly’s stock dipped after its Q4 guidance came in lower than expected. ...

Can Eli Lilly capitalize on orforglipron?

LLY’s key target market is set to grow rapidly over the next two years, and the company is well-positioned to capitalize on it—especially with the launch of its oral weight-loss drug, Orforglipron. Eli Lilly is set to report Q4 2024 earnings on February 6, 2025, with management expecting $13.5 billion in revenue—a massive 45% year-over-year jump. ...

How can investors track Lilly's earnings estimate revisions?

Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Lilly: mixed. ...

What makes Eli Lilly so successful?

Eli Lilly’s momentum stems from blockbuster GLP-1 therapies (Mounjaro, Zepbound), fuelling revenue growth, long-term margin expansion, and an ethos driving America’s health focus across obesity and beyond. ...